Close
American Drug Delivery & Formulation Summit
Xylem

Mene Pangalos elected to the Fellowship of the Academy of Medical Sciences

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

In Vivo CAR-T Engineering Sets a New Oncology Standard

The emergence of chimeric antigen receptor T cell therapy...

Proximity Therapeutics Unlock New Druggable Frontiers

The pharmaceutical industry has historically focused on a narrow...

AI Automation Is Accelerating Drug Discovery at Scale

The traditional pharmaceutical research and development model has long...
- Advertisement -

IMED leader one of 48 new fellows recognised for the advancement of medical science in the UK

Each year the Academy of Medical Sciences elect a small number of UK scientists to their Fellowship in recognition of their contribution to the advancement of medical science. Potential Academy Fellows are nominated for election based on their excellence in medical research, their innovative application of scientific knowledge or for their service to healthcare.

Earlier today, it was announced that Mene Pangalos, Executive Vice President of our Innovative Medicines and Early Development Biotech Unit, has been elected as one of just 48 new Fellows – out of more than 350 nominations.

On hearing the news, Mene commented: โ€œItโ€™s a great honour to be elected as a Fellow of the Academy of Medical Sciences. I am looking forward to working with the Fellowship to drive greater connections between academia, industry and the NHS and to develop new ways to inspire the next generation of UK scientists.โ€

ย 

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

In Vivo CAR-T Engineering Sets a New Oncology Standard

The emergence of chimeric antigen receptor T cell therapy...

Proximity Therapeutics Unlock New Druggable Frontiers

The pharmaceutical industry has historically focused on a narrow...

AI Automation Is Accelerating Drug Discovery at Scale

The traditional pharmaceutical research and development model has long...

Digital Health Tools Are Transforming Patient Care Models

The integration of advanced technology into the clinical environment...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป